Company performance
Current Price
as of Mar 14, 2025$97.40
P/E Ratio
60.23
Market Cap
$1.75B
Loading...
Description
Pharma Mar SA is a biopharmaceutical holding company, which engages in research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It operates through the following segments: Oncology, Diagnostics, and RNAi. The Oncology segment focuses to the group undertakings whose object is to research, develop, and market anti-tumour drugs. The Diagnostics segment focuses in the development and marketing of diagnostic kits. The RNAi segment develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was founded by José Maria Fernández de Sousa-Faro on April 30, 1986 and is headquartered in Colmenar Viejo, Spain.
Metrics
Overview
- HQColmenar Viejo, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Other
- TickerPHM
- Price$97.39925+1.24%
Trading Information
- Market cap$1.75B
- Float74.97%
- Average Daily Volume (1m)70,678
- Average Daily Volume (3m)63,690
- EPS$1.49
Company
- Revenue$174.86M
- Rev growth (1yr)10.56%
- Net income$26.13M
- Gross margin95.32%
- EBITDA margin5.34%
- EBITDA$9.34M
- EVN/A
- EV/RevenueN/A
- P/E60.23
- P/S9.05
- P/B8.69
- Debt/Equity24.51